tiprankstipranks
China NT Pharma Explores Debt-to-Equity Conversion
Company Announcements

China NT Pharma Explores Debt-to-Equity Conversion

China NT Pharma Group Co., Ltd. (HK:1011) has released an update.

Don't Miss our Black Friday Offers:

China NT Pharma Group Co., Ltd. has observed unusual share price movements and is considering issuing new shares to four creditors, possibly affecting control of the company if a single creditor’s share exceeds 30%. The company is negotiating possible subscriptions that would convert existing loans into equity but cautions that no agreements have been finalized, and the outcome remains uncertain. Trading in the company’s shares, which was halted, is set to resume following this announcement.

For further insights into HK:1011 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App